136 related articles for article (PubMed ID: 33290292)
21. Bone mineral density in children with acute lymphoblastic leukemia.
Inaba H; Cao X; Han AQ; Panetta JC; Ness KK; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Cheng C; Pui CH; Relling MV; Kaste SC
Cancer; 2018 Mar; 124(5):1025-1035. PubMed ID: 29266176
[TBL] [Abstract][Full Text] [Related]
22. The Association of Oral Vitamin D and Calcium Supplementation With Bone Mineral Density in Pediatric Acute Lymphoblastic Leukemia Patients.
Demirsoy U; Sarper N; Aylan Gelen S; Zengin E; Kum T; Demir H
J Pediatr Hematol Oncol; 2017 May; 39(4):287-292. PubMed ID: 28234736
[TBL] [Abstract][Full Text] [Related]
23. Severe hypertriglyceridemia during treatment of acute lymphoblastic leukemia associated with type III hyperlipoproteinemia.
Yamada Y; Shima H; Shibata H; Ishii T; Hasegawa T; Shimada H
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28371240
[No Abstract] [Full Text] [Related]
24. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.
Halton JM; Atkinson SA; Fraher L; Webber C; Gill GJ; Dawson S; Barr RD
J Bone Miner Res; 1996 Nov; 11(11):1774-83. PubMed ID: 8915786
[TBL] [Abstract][Full Text] [Related]
25. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
26. Incidence of aseptic osteonecrosis following the therapy of childhood leukemia.
Bömelburg T; von Lengerke HJ; Ritter J
Haematol Blood Transfus; 1990; 33():577-9. PubMed ID: 2323658
[No Abstract] [Full Text] [Related]
27. Risk factors and management of corticosteroid-induced hyperglycaemia in paediatric acute lymphoblastic leukaemia.
Gregoriou K; Craigie I; Gibson B; Mason A; Shaikh MG
Pediatr Blood Cancer; 2020 Feb; 67(2):e28085. PubMed ID: 31736211
[TBL] [Abstract][Full Text] [Related]
28. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
29. Effect of 1,25(OH)2-vitamin D on bone mass in children with acute lymphoblastic leukemia.
Díaz PR; Neira LC; Fischer SG; Teresa Torres MC; Milinarsky AT; Giadrosich VR; Arriagada MM; Arinoviche RS; Casanova DM
J Pediatr Hematol Oncol; 2008 Jan; 30(1):15-9. PubMed ID: 18176174
[TBL] [Abstract][Full Text] [Related]
30. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
31. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
32. Bronchial asthma and acute lymphoblastic leukemia in childhood.
Katzilakis N; Paraskakis E; Mantadakis E; Stiakaki E; Kalmanti M
Pediatr Pulmonol; 2008 Feb; 43(2):206. PubMed ID: 18085680
[No Abstract] [Full Text] [Related]
33. Measuring neurobehavioral side effects of corticosteroids in pediatric acute lymphoblastic leukemia: A scoping review.
Bhasin S; Brown J; Dorste A; Samsel C; Vrooman LM; Muriel AC
Pediatr Blood Cancer; 2024 Apr; 71(4):e30881. PubMed ID: 38263506
[TBL] [Abstract][Full Text] [Related]
34. A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study.
Caubet Fernandez M; Drouin S; Samoilenko M; Morel S; Krajinovic M; Laverdière C; Sinnett D; Levy E; Marcil V; Lefebvre G
BMC Med Res Methodol; 2019 May; 19(1):100. PubMed ID: 31088361
[TBL] [Abstract][Full Text] [Related]
35. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia.
Atkinson SA; Fraher L; Gundberg CM; Andrew M; Pai M; Barr RD
J Pediatr; 1989 May; 114(5):793-800. PubMed ID: 2785592
[TBL] [Abstract][Full Text] [Related]
36. Bone mass after treatment for acute lymphoblastic leukemia in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
J Clin Oncol; 1998 Dec; 16(12):3752-60. PubMed ID: 9850018
[TBL] [Abstract][Full Text] [Related]
37. Permanent insulin-dependent diabetes mellitus in a patient with acute lymphoblastic leukemia.
Akane Y; Yamamoto M; Igarashi K; Takebayashi A; Hori T
Pediatr Int; 2020 Mar; 62(3):403-405. PubMed ID: 32022381
[No Abstract] [Full Text] [Related]
38. Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.
Kaushik A; Bansal D; Khandelwal N; Trehan A; Marwaha RK
Indian Pediatr; 2009 Mar; 46(3):245-8. PubMed ID: 19213989
[TBL] [Abstract][Full Text] [Related]
39. [Effect of E coli or Erwinia asparaginase and corticotherapy on fibrinogen concentration in induction of acute lymphoblastic leukemia in children].
Astruc D; Nowak V; Grunebaum L; Wiesel ML; Cazenave JP; Babin-Boilletot A; Lutz P
Arch Pediatr; 1994 Jun; 1(6):617-8. PubMed ID: 7994359
[No Abstract] [Full Text] [Related]
40. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia.
Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K
Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
